Connect Biopharma (CNTB) vs Pliant Therapeutics (PLRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pliant Therapeutics (PLRX) has outperformed Connect Biopharma (CNTB) over the past year, losing 33.1% versus a loss of 46.9%. Over five years, PLRX leads with a -94.5% price change compared with -94.5% for CNTB. Pliant Therapeutics is the larger company by market cap ($61.3 million vs $59.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTB | PLRX |
|---|---|---|
| Share price | $0.9447 | $0.99 |
| Market cap | $59.49M | $61.30M |
| 1-day change | +4.34% | -3.88% |
| YTD return | -66.50% | -18.85% |
| 1-year return | -46.93% | -33.11% |
| 5-year return | -94.50% | -94.50% |
| EPS (TTM) | $-1.25 | $-1.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.82 | $1.95 |
| 52-week low | $0.85 | $0.97 |
| Distance from 52-week high | -75.27% | -49.23% |
| Average volume | 3.82M | 488.25K |
| Shares outstanding | 62.97M | 61.92M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLRX has outperformed CNTB by 13.8 percentage points over the past year.
CNTB vs PLRX FAQ
Which is bigger, Connect Biopharma or Pliant Therapeutics?
Pliant Therapeutics (PLRX) is larger, with a market capitalization of $61.30M compared with $59.49M for Connect Biopharma (CNTB).
Which stock has performed better over the past year, CNTB or PLRX?
PLRX returned -33.11% over the past 12 months, compared with -46.93% for CNTB (price return, excluding dividends). Past performance does not predict future results.
Are Connect Biopharma and Pliant Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.